Advanced Enzyme Technologies Increases Investment in Wholly Owned Subsidiary Advanced Nutrazyme Private Limited
Advanced Enzyme Technologies Limited has completed an additional investment in its wholly owned subsidiary, Advanced Nutrazyme Private Limited (ANPL). The investment was made through a rights issue involving 2,50,000 Equity Shares of ₹ 10 each.The injection of capital by the company brings the total investment into ANPL to ₹ 3 million. This investment activity increased AETL’s holding in ANPL to 3,00,000 Equity Shares of ₹ 10 each.
ADVENZYMES Stock Price Movement
Shares of Advanced Enzyme Technologies Limited slipped on Friday, settling at ₹367.05 after shedding 2.52% in trading. The stock recorded a traded volume of 155,728 shares, which saw it fall from its previous closing price of ₹376.50.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.